Seagen
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 2,108 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 2,232 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 34,216 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 103,552 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 26,145 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 563 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 8,639 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 7,680 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 23,244 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 502 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 797 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 36,983 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 12,220 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,052 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 16,117 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 48,776 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 645 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 9,895 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 29,946 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 28,825 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 87,236 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,881 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 31,197 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,447,207 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 478,196 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 18,230 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 278,650 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 832,135 N/A N/A
Purchase
AKKARAJU SRINIVAS director
 Warrants 132,331 N/A N/A
Sale
JP MORGAN PARTNERS BHCA LP 10 percent owner
 Warrants 132,331 N/A N/A
Purchase
JP MORGAN PARTNERS BHCA LP 10 percent owner
 Series A Convertible Preferred Stock 105,864 N/A N/A
Sale
JP MORGAN PARTNERS BHCA LP 10 percent owner
 Series A Convertible Preferred Stock 105,864 N/A N/A
Sale
AKKARAJU SRINIVAS director
 Series A Convertible Preferred Stock 211,728 N/A N/A
Sale
AKKARAJU SRINIVAS director
 Warrants 132,331 N/A N/A
Purchase
AKKARAJU SRINIVAS director
 Series A Convertible Preferred Stock 105,864 N/A N/A
Purchase
JP MORGAN PARTNERS BHCA LP 10 percent owner
 Warrants 132,331 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 73,000 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 2,000 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 2,000 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 20,000 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 9,000 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 42,500 N/A N/A
Sale
SIEGALL CLAY B director, officer: President an..
 Common Stock 51,500 N/A N/A
Sale
CARROLL TIM officer: CFO
 Common Stock 40,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL II (GP), LLC 10 percent owner
 Common Stock 6,627 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,448 N/A N/A
Sale
CARROLL TIM officer: CFO
 Common Stock 26,500 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 7,241 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 678 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 531 N/A N/A

Showing 1850 to 1900 of 2081 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: